A detailed history of Larson Financial Group LLC transactions in Vaxart, Inc. stock. As of the latest transaction made, Larson Financial Group LLC holds 156 shares of VXRT stock, worth $90. This represents 0.0% of its overall portfolio holdings.

Number of Shares
156
Previous 156 -0.0%
Holding current value
$90
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 10, 2021

BUY
$5.06 - $10.78 $151 - $323
30 Added 23.81%
156 $1,000
Q3 2020

Oct 08, 2020

BUY
$4.78 - $16.97 $602 - $2,138
126 New
126 $1,000

Others Institutions Holding VXRT

About Vaxart, Inc.


  • Ticker VXRT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 126,506,000
  • Market Cap $73.4M
  • Description
  • Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI.1...
More about VXRT
Track This Portfolio

Track Larson Financial Group LLC Portfolio

Follow Larson Financial Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Larson Financial Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Larson Financial Group LLC with notifications on news.